nsc-4347 and Mouth-Neoplasms

This systematic review and meta-analysis aimed to critically appraised data from comparable studies leading to quantitative assessment of any independent association between use of oral smokeless tobacco in any form, of betel quid without tobacco and of areca nut with incidence of oral cancer in South Asia and the Pacific.. Studies (case control and/or cohort) were identified by searching Pub Med, CINAHL and Cochrane databases through June 2013 using the keywords oral cancer: chewing tobacco; smokeless tobacco; betel quid; betel quid without tobacco; areca nut; Asia, the Pacific and the reference lists of retrieved articles. A random effects model was used to compute adjusted summary OR(RE) for the main effect of these habits along with their corresponding 95% confidence intervals. To quantify the impact of between-study heterogeneity on adjusted main-effect summary OR(RE), Higgins' H and I2 statistics along with their 95% uncertainty intervals were used. Funnel plots and Egger's test were used to evaluate publication bias.. Meta-analysis of fifteen case-control studies (4,553 cases; 8,632 controls) and four cohort studies (15,342) which met our inclusion criteria showed that chewing tobacco is significantly and independently associated with an increased risk of squamous-cell carcinoma of the oral cavity (adjusted main-effect summary for case- control studies OR(RE) = 7.46; 95% CI = 5.86-9.50, P<0.001), (adjusted main-effect summary for cohort studies RR = 5.48; 95% CI = 2.56-11.71, P<0.001). Furthermore, meta-analysis of fifteen case control studies (4,648 cases; 7,847 controls) has shown betel quid without tobacco to have an independent positive association with oral cancer, with OR = 2.82 (95% CI = 2.35-3.40, P<0.001). This is presumably due to the carcinogenicity of areca nut. There was no significant publication bias.. There is convincing evidence that smokeless (aka chewing) tobacco, often used as a component of betel quid, and betel quid without tobacco, are both strong and independent risk factors for oral cancer in these populations. However, studies with better separation of the types of tobacco and the ways in which it is used, and studies with sufficient power to quantify dose-response relationships are still needed.

Topics: Asia; Case-Control Studies; Cohort Studies; Databases, Factual; Humans; Mouth Neoplasms; Odds Ratio; Pacific Islands; Piper; Plant Leaves; Tobacco, Smokeless

Oral squamous cell carcinoma (OSCC) is the most common type of head and neck malignancy. Research on essential oils (EOs) has shown important cytotoxic and anti-tumor properties, among others. Piperaceae species are rich in EOs and here we highlight

Topics: Bicyclic Monoterpenes; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Mouth Neoplasms; Oils, Volatile; Piper; Plants, Medicinal; Squamous Cell Carcinoma of Head and Neck

The oral squamous cell carcinoma (OSCC) is the eighth more common cancer in men. The development of new and more efficient drugs is needed. Plants of the genus

Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Head and Neck Neoplasms; Humans; Male; Mouth Neoplasms; Piper; Plant Extracts; Squamous Cell Carcinoma of Head and Neck

Oral squamous cell carcinoma (OSCC) is one of the ten most common types of cancer worldwide. Plants of the genusPiper are used in traditional medicine to treat cancer, and they have a vast diversity of phytochemicals with cytotoxic potential. Purpose and Study Design: In this work, we analyzed the cytotoxic and selective potential of extracts and semipurified fractions of Piper mollicomum (PM), Piper truncatum (PT), Piper cernuum (PC), Piper arboreum (PA), and Piper cabralanum (PCa) using three different OSCC cell lines (SCC4, SCC9 and SCC25), and we measured their in vivo toxicities and conducted chemical analyses of their active fractions.. PC-L-D demonstrated great potential for further development as an anticancer drug and could be the key to developing more effective and less toxic therapies against oral cancer.

Topics: Animals; Antineoplastic Agents, Phytogenic; Brazil; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cytotoxins; Dose-Response Relationship, Drug; Humans; Male; Mice; Mice, Inbred C57BL; Mouth Neoplasms; Piper; Plant Extracts

Betel quid (BQ) is a widely accepted etiological factor for oral squamous cell carcinoma (OSCC) in Southeast Asia, but how BQ chewing leads to oral carcinogenesis remains to be elucidated. We have previously demonstrated that the activation of Src family kinases (SFKs) is critical for BQ-induced oral cancer cell motility. Here we investigate whether this biological effect is mediated by specific membrane receptors in oral cancer cells. We found that BQ-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and cell migration could be inhibited by atropine, suggesting the involvement of the muscarinic receptor family. The enhanced activities of ERK1/2 and cell migration were significantly counteracted by PD102807, the selective antagonist of muscarinic M4 receptor. Moreover, cold BQ extract effectively competed with a known ligand, [(3)H]-N-methyl scopolamine, for binding to muscarinic M4 receptor in vitro, thereby implying that BQ could activate motility-promoting signaling pathways through direct interaction with the receptor. The requirement of muscarinic M4 receptor for BQ-induced oral cancer cell migration was demonstrated by knockdown of the receptor using RNA interference (RNAi). Remarkably, ectopic expression of muscarinic M4 receptor in two oral cancer cell lines, Ca9-22 and SCC-9, further augmented BQ-induced cell migration by 83% and 99%, respectively. Finally, we verified that BQ-induced oral cancer cell migration was mediated through a muscarinic M4 receptor-->SFKs-->ERK1/2 signaling pathway. Thus, our findings have identified a novel signaling cascade mediating BQ-induced oral cancer cell motility, which could be a therapeutic target for BQ-related oral malignancies.

Topics: Calcium Compounds; Cell Line, Tumor; Cell Movement; Humans; Mastication; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mouth Neoplasms; Oxides; Piper; Plant Extracts; Receptor, Muscarinic M4; Signal Transduction

Epidemiological evidence suggests that chewing betel quid and smoking have synergistic potential in the development of oral squamous-cell carcinoma in Taiwan. Chewing betel quid produces alkalization of saliva. This study investigated the response of human oral cancer OEC-M1 cells to nicotine in different pH environments (6.5 and 8) by examining its effects on DNA damage as evidenced by single-cell gel electrophoresis. Nicotine (1 and 10 muM) significantly induced DNA strand breakage when cultured at pH 8 for 6 h but did not induce DNA damage at pH 6.5. Nicotine-induced DNA damage was also time dependent. When cells were pretreated with catalase or N-acetylcysteine, a significant reduction in nicotine-induced DNA damage was observed. Flow cytometric analyses showed that the production of 8-oxoguanine was significantly increased following nicotine (10 muM) treatment. Posttreatment of nicotine-damaged DNA by endonuclease III and formamidopyrimidine-DNA glycosylase, recognizing oxidized DNA bases, increased the extent of DNA damage. These results suggest that nicotine-induced DNA strand breakage is pH dependent, and oxidative stress might be involved in nicotine-induced DNA damage. Finally, cigarette smoke condensate (equivalent to 8 muM nicotine) induced significant DNA strand breaks in OEC-M1 cells at pH 8 and correlated with the generation of oxidative DNA damage. Thus, alkaline saliva generated by chewing betel quid plays an important role in cigarette-related nicotine-induced DNA damage, and reactive oxygen species may be involved in generating this DNA damage.

Topics: Acetylcysteine; Calcium Compounds; Catalase; Cell Line, Tumor; Comet Assay; DNA Damage; Drug Synergism; Guanine; Humans; Hydrogen-Ion Concentration; Mouth Neoplasms; Nicotiana; Nicotine; Oxidative Stress; Oxides; Piper; Plant Extracts; Smoke; Taiwan